Lineage Cell Therapeutics...

AMEX: LCTX · Real-Time Price · USD
1.02
-0.01 (-0.97%)
At close: Aug 14, 2025, 3:59 PM
1.03
0.97%
Pre-market: Aug 15, 2025, 08:39 AM EDT

Lineage Cell Therapeutics Revenue

Lineage Cell Therapeutics reported an annual revenue of $9.5M, reflecting a 6.19% growth. For the quarter ending June 30, 2025, Lineage Cell Therapeutics generated $2.77M in revenue.
Revenue (ttm)
9.5M
Revenue Growth
6.19%
Price / Sales Ratio
10.59
Revenue / Employee
135.7K
Employees
70
Market Cap
232.92M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.